Proteomics International and Sonic Healthcare USA sign exclusive license agreement to take PromarkerD to the US market
Proteomics International Laboratories Ltd (Proteomics International; the Company; ASX: PIQ) is pleased to announce it has signed an exclusive license agreement with Sonic Healthcare USA, a Division of Sonic Healthcare Ltd (OTCMKTS: SKHHY) for the use and commercialization of the Company's PromarkerD test for diabetic kidney disease in the United States. Under the agreement, Sonic Healthcare USA will be offering PromarkerD to physicians and healthcare systems through its client engagement teams across the US.
Welcome to Sonic Healthcare USA
Sonic Healthcare USA is a division of Sonic Healthcare Limited, one of the largest diagnostic laboratory medicine companies in the world. We aspire to help people live better, healthier lives. We focus on delivering the highest quality laboratory information through our unique Medical Leadership model and federated structure, through regional diagnostic laboratories operating across the United States.
Since its establishment in 2007, Sonic Healthcare USA has grown to become the third largest laboratory medicine company in the United States, with operations across the country. From our boardroom to our individual practices, we are guided by the leadership of our medical specialists, senior scientists experienced managers, all of whom understand the unique demands and privileges of working to improve the health of our patients.